Nevro Lands $58,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43f43f65-2991-46db-90d1-dde3ffc96c6d&Preview=1 -
Date
7/20/2011 -
Company Name
Nevro -
Mailing Address
4040 Campbell Avenue Menlo Park, CA 94025 -
Company Description
Nevro is a medical device company developing novel neuromodulation therapies for multiple indications. The company’s initial focus is the development of an implantable device for the treatment of chronic pain. -
Website
http://www.nevrocorp.com -
Transaction Type
Venture Equity -
Transaction Amount
$58,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The funds will be used to sponsor a pivotal clinical study in the U.S. and provide continued support for the company’s international commercialization strategy. -
M&A Terms
-
Venture Investor
Johnson & Johnson Development Corporation -
Venture Investor
Aberdare Ventures -
Venture Investor
Three Arch Partners -
Venture Investor
Bay City Capital -
Venture Investor
Accuitive Medical Ventures -
Venture Investor
Mayo Medical Ventures -
Venture Investor
MPM Capital
